Zevra Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$10.26

+0.16 (+1.58%)

As of Nov 7, 2:03 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -48.0% upside

Low Target $3.67

Average Target $5.34

High Target $6.76

Current Price $10.26

Current
$10.26

Target
$5.34

$3.67 $5.34 avg $6.76

Scenario Analysis

Bear Case

$3.67

-64.2%

Low target

Base Case

$5.34

-48.0%

Avg target

Bull Case

$6.76

+-34.1%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$15.04

-31.8% from high

52-Week Low

$8.01

+28.1% from low

Target vs 52W High

$5.34

-64.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+164.3%